Drug giant Pfizer says it will not split into two publicly traded companies, despite pressure from investors frustrated by its lagging stock price, ending years of Wall Street speculation over its strategy and future.
The biggest US-based drugmaker on Monday said that it believes it is best positioned to maximize shareholder value in its current form, but it reserves the right to split if the situation changes.
For several years, the maker of Viagra and pain treatment Lyrica has been under pressure from analysts and investors who argued that by splitting up, the resulting two companies might grow faster than one.
Photo: Bloomberg
As a result, Pfizer has been reporting detailed financial results for each of its business segments, information that would be required by regulators for a split.
Earlier this year, Pfizer promised a decision by the end of the year, but then it reorganized and renamed those segments — a sign a breakup was less likely.
Chances of the breakup began to fade even more over the summer, due in part to increasing sales for key new drugs from Pfizer and rising prospects for its drugs under development.
Pfizer CEO Ian Read told analysts last month that the prospect of a split was not a “make-or-break decision” for the company.
The firm recently said it had spent US$600 million on preparations for such a split.
“Given that Pfizer has been talking down expectations for a separation in recent months, we think the stock will only be down modestly on this news,” Jeffries analyst Jeffrey Holford wrote to investors.
Pfizer said that a split would not help the competitive positioning of its businesses and such a move would create disruptions and increased costs.
The drugmaker’s most likely path forward involves hunting for more acquisition targets, said Bernstein analyst Tim Anderson, who had pressed Pfizer repeatedly on its quarterly results conference calls to break up.
Pfizer has been buying several companies and products to help make up for a wave of sales losses to cheaper, generic competition, most notably for the cholesterol pill Lipitor.
It also attempted and failed at two mega-acquisitions, of Britain’s AstraZeneca PLC in 2014 and this year of Ireland’s Allergan PLC.
Both those deals had been structured as tax inversions, meant to allow Pfizer to move its headquarters from New York — but just on paper — to a country with lower tax rates to reduce its US tax bill.
AstraZeneca rebuffed Pfizer and the US Treasury Department set up new rules that effectively blocked the Allergan acquisition.
Last month, Pfizer said it would spend about US$14 billion to buy cancer drug developer Medivation and it is buying rights to AstraZeneca’s portfolio of approved and experimental antibiotic and antifungal pills.
In June, Pfizer completed a US$5.2-billion acquisition of Anacor Pharmaceuticals Inc, which could get a new eczema drug, Crisaborole, approved by January next year.
“A critic could argue that Pfizer is back to being the same old Pfizer as before, relying on [mergers and acquisitions] to grow and to refill its pipeline, but at the expense of growing larger in the process depending on the size of deals it chases,” Anderson said in a research note.
DECOUPLING? In a sign of deeper US-China technology decoupling, Apple has held initial talks about using Baidu’s generative AI technology in its iPhones, the Wall Street Journal said China has introduced guidelines to phase out US microprocessors from Intel Corp and Advanced Micro Devices Inc (AMD) from government PCs and servers, the Financial Times reported yesterday. The procurement guidance also seeks to sideline Microsoft Corp’s Windows operating system and foreign-made database software in favor of domestic options, the report said. Chinese officials have begun following the guidelines, which were unveiled in December last year, the report said. They order government agencies above the township level to include criteria requiring “safe and reliable” processors and operating systems when making purchases, the newspaper said. The US has been aiming to boost domestic semiconductor
Nvidia Corp earned its US$2.2 trillion market cap by producing artificial intelligence (AI) chips that have become the lifeblood powering the new era of generative AI developers from start-ups to Microsoft Corp, OpenAI and Google parent Alphabet Inc. Almost as important to its hardware is the company’s nearly 20 years’ worth of computer code, which helps make competition with the company nearly impossible. More than 4 million global developers rely on Nvidia’s CUDA software platform to build AI and other apps. Now a coalition of tech companies that includes Qualcomm Inc, Google and Intel Corp plans to loosen Nvidia’s chokehold by going
ENERGY IMPACT: The electricity rate hike is expected to add about NT$4 billion to TSMC’s electricity bill a year and cut its annual earnings per share by about NT$0.154 Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has left its long-term gross margin target unchanged despite the government deciding on Friday to raise electricity rates. One of the heaviest power consuming manufacturers in Taiwan, TSMC said it always respects the government’s energy policy and would continue to operate its fabs by making efforts in energy conservation. The chipmaker said it has left a long-term goal of more than 53 percent in gross margin unchanged. The Ministry of Economic Affairs concluded a power rate evaluation meeting on Friday, announcing electricity tariffs would go up by 11 percent on average to about NT$3.4518 per kilowatt-hour (kWh)
OPENING ADDRESS: The CEO is to give a speech on the future of high-performance computing and artificial intelligence at the trade show’s opening on June 3, TAITRA said Advanced Micro Devices Inc (AMD) chairperson and chief executive officer Lisa Su (蘇姿丰) is to deliver the opening keynote speech at Computex Taipei this year, the event’s organizer said in a statement yesterday. Su is to give a speech on the future of high-performance computing (HPC) in the artificial intelligence (AI) era to open Computex, one of the world’s largest computer and technology trade events, at 9:30am on June 3, the Taiwan External Trade Development Council (TAITRA) said. Su is to explore how AMD and the company’s strategic technology partners are pushing the limits of AI and HPC, from data centers to